Medipal Holdings Corp
TSE:7459
Intrinsic Value
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. [ Read More ]
The intrinsic value of one
Medipal Holdings Corp
stock under the Base Case scenario is
7 865.27
JPY.
Compared to the current market price of 2 385 JPY,
Medipal Holdings Corp
is
Undervalued by 70%.
Medipal Holdings Corp could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Medipal Holdings Corp's market capitalization is 500.9B JPY.
Medipal Holdings Corp stock price is 2 385 JPY.
Medipal Holdings Corp stock price (2385 JPY) is 70% less than its Intrinsic Value (7 865.27 JPY).
Medipal Holdings Corp stock price (2385 JPY) is 77% less than its DCF Value (10 370.39 JPY). Open DCF Valuation
Medipal Holdings Corp stock price (2385 JPY) is 56% less than its Relative Value (5 360.14 JPY). Open Relative Valuation
Medipal Holdings Corp has upside potential of 7% compared to the average analyst price target.
Open Wall St Estimates
Medipal Holdings Corp's Altman Z-Score is equal to 2.5.
Medipal Holdings Corp's ROIC (Return on Invested Capital) has increased in the last 3 years from 5% to 6%.
Medipal Holdings Corp's Revenue has grown by 5% over the past 12 months.
Medipal Holdings Corp has positive Free Cash Flow for the last twelve months.
Medipal Holdings Corp's ROE (Return on Equity) has increased in the last 3 years from 5% to 7%.
Medipal Holdings Corp's Revenue is forecast to grow at a rate of 3% per year over the next 3 years.
Medipal Holdings Corp's Revenue has been growing by 3% per year for the last 3 years.
Medipal Holdings Corp's ROE (Return on Equity) for the past 12 months is positive and is equal to 7%.
Medipal Holdings Corp's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 6%.
Medipal Holdings Corp's short-term assets (1T JPY) exceed its short-term liabilties (1T JPY).
Medipal Holdings Corp has positive Gross Profit for the last twelve months.
Medipal Holdings Corp has positive three-year average ROE (Return on Equity): 6%. The company is efficient at transforming stockholders' equity into net income.
Medipal Holdings Corp's long-term assets (2T JPY) exceed its long-term liabilties (1T JPY).
Medipal Holdings Corp has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
Medipal Holdings Corp has positive Operating Income for the last twelve months.
Medipal Holdings Corp has positive Net Income for the last twelve months.
Medipal Holdings Corp's D/E (Debt to Equity) is very low and is equal to 0.
Medipal Holdings Corp earns more than enough operating income (49B JPY) to safely cover interest payments on its debt (32m JPY).
Valuation Backtest
Medipal Holdings Corp
Run backtest to discover the historical profit from buying and selling
Medipal Holdings Corp
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Medipal Holdings Corp
Balance Sheet Decomposition
Medipal Holdings Corp
| Current Assets | 1.3T |
| Cash & Short-Term Investments | 214.7B |
| Receivables | 814.4B |
| Other Current Assets | 299.5B |
| Non-Current Assets | 545.1B |
| Long-Term Investments | 200.4B |
| PP&E | 272.5B |
| Intangibles | 39.7B |
| Other Non-Current Assets | 32.6B |
| Current Liabilities | 1.1T |
| Accounts Payable | 1T |
| Accrued Liabilities | 3.6B |
| Other Current Liabilities | 73.3B |
| Non-Current Liabilities | 185B |
| Other Non-Current Liabilities | 185B |
Earnings Waterfall
Medipal Holdings Corp
|
Revenue
|
3.5T
JPY
|
|
Cost of Revenue
|
-3.3T
JPY
|
|
Gross Profit
|
240.3B
JPY
|
|
Operating Expenses
|
-191.6B
JPY
|
|
Operating Income
|
48.7B
JPY
|
|
Other Expenses
|
-11.4B
JPY
|
|
Net Income
|
37.2B
JPY
|
Free Cash Flow Analysis
Medipal Holdings Corp
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Medipal Holdings Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Medipal Holdings Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medipal Holdings Corp's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Medipal Holdings Corp's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medipal Holdings Corp
According to Wall Street analysts, the average 1-year price target for
Medipal Holdings Corp
is 2 560.2 JPY
with a low forecast of 2 020 JPY and a high forecast of 3 150 JPY.
Shareholder Return
Price
Medipal Holdings Corp
| Average Annual Return | -6.46% |
| Standard Deviation of Annual Returns | 14.97% |
| Max Drawdown | -34% |
| Market Capitalization | 500.9B JPY |
| Shares Outstanding | 190 900 384 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Medipal Holdings Corp
Country
Industry
Market Cap
Dividend Yield
Description
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 12,971 full-time employees. The firm operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The firm is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Medipal Holdings Corp
stock under the Base Case scenario is
7 865.27
JPY.
Compared to the current market price of 2 385 JPY,
Medipal Holdings Corp
is
Undervalued by 70%.
You don't have any saved screeners yet
